5-Carboxystrictosidine

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 130110

CAS#: 34371-47-6

Description: 5-Carboxystrictosidine, which is found in the medicinal Mappianthus iodoides Hand.-Mazz. root, is a mitochondrial KATP channel activator with evidence suggestive of its potential use to prevent I/R injury of the heart. It was suggested the protective effects may be a result of antioxidant and decreased apoptotic effects achieved through the opening of mitochondrial KATP channels.


Chemical Structure

img
5-Carboxystrictosidine
CAS# 34371-47-6

Theoretical Analysis

MedKoo Cat#: 130110
Name: 5-Carboxystrictosidine
CAS#: 34371-47-6
Chemical Formula: C28H34N2O11
Exact Mass: 574.22
Molecular Weight: 574.580
Elemental Analysis: C, 58.53; H, 5.96; N, 4.88; O, 30.63

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: 5-Carboxystrictosidine; 5 Carboxystrictosidine; 5Carboxystrictosidine; 5(S)-5-carboxystrictosidine; (5S)-5-carboxystrictosidine

IUPAC/Chemical Name: (1S,3S)-1-(((2S,3R,4S)-5-(methoxycarbonyl)-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-3-vinyl-3,4-dihydro-2H-pyran-4-yl)methyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid

InChi Key: LHKZIVMTXZLOTP-RMKGEEGASA-N

InChi Code: InChI=1S/C28H34N2O11/c1-3-12-14(8-18-21-15(9-19(29-18)25(35)36)13-6-4-5-7-17(13)30-21)16(26(37)38-2)11-39-27(12)41-28-24(34)23(33)22(32)20(10-31)40-28/h3-7,11-12,14,18-20,22-24,27-34H,1,8-10H2,2H3,(H,35,36)/t12-,14+,18+,19+,20-,22-,23+,24-,27+,28+/m1/s1

SMILES Code: O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O[C@@H]2OC=C(C(OC)=O)[C@@H](C[C@H]3C4=C(C5=CC=CC=C5N4)C[C@@H](C(O)=O)N3)[C@H]2C=C)[C@@H]1O

Appearance: To be determined

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 574.58 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1. Han Y, Li C, Zhang P, Yang X, Min J, Wu Q, Xie Y, Jin D, Wang Z, Shao F, Quan H. Protective effects of 5(S)-5-carboxystrictosidine on myocardial ischemia-reperfusion injury through activation of mitochondrial KATP channels. Eur J Pharmacol. 2022 Apr 5;920:174811. doi: 10.1016/j.ejphar.2022.174811. Epub 2022 Feb 17. PMID: 35182546.